Ric Day

92 posts

Ric Day

Ric Day

@osbornidayius

Beigetreten Mayıs 2017
39 Folgt108 Follower
Ric Day
Ric Day@osbornidayius·
@UNSWMedicine @LaurentJBillot @UNSW @georgeinstitute There was no contrast in quality of life or function at any time up to 12months comparing opioids taken for up to 6 weeks with placebo. Opioids associated with higher risk of opioid misuse at 12 months.
English
0
0
0
36
Ric Day retweetet
A/Prof Carissa Bonner
A/Prof Carissa Bonner@carissa_bon·
Practice changing paper by @wiserhealthcare ECR star @Caitlin_Jones, showing opioids are not effective for acute back/ neck pain. @sydFMH_EMCR @syd_health
Caitlin Jones@Caitlin_Jones_

📢Out today in @Lancet: major @msk_health led trial finds #opioids NOT effective for people with acute back and/or neck pain. This is the largest placebo controlled trial of its kind. doi.org/10.1016/S0140-… #OPALtrial #backpain #neckpain

English
5
5
12
5.2K
Ric Day retweetet
Andrew McLachlan
Andrew McLachlan@AndMacUSyd·
This trail used the recommended dose range for oxycodone-naloxone combination from the Australian Medicines Handbook "oxycodone/naloxone 5/2.5–10/5 mg every 12 hours; adjust dose according to response after 1 week or less"
Liam Mannix@liammannix

@safesupplysaves the researchers wanted to focus on acute low back pain without an underlying pathology - which is about 90%+ of all cases from a quick look, 10mg seems to be a fairly standard dose for acute pain. @AndMacUSyd may have more info

English
10
6
19
3.1K
Ric Day retweetet
Andrew McLachlan
Andrew McLachlan@AndMacUSyd·
British Journal of Clinical Pharmacology (BJCP)@BritJClinPharm

Rising #gabapentinoid misuse is being recognised alongside the lack of current evidence supporting the safe and effective deprescribing of them. This scoping review assesses the extent and nature of deprescribing interventions in adults: ow.ly/lYcW50OKjUC #gabapentinoids

English
2
5
13
1.5K
Chris Maher
Chris Maher@CGMMaher·
First today at parkrun; and my best age graded score ever: 92.27% Unfortunately not the monthly @msk_health run so no-one will believe me 😟
Chris Maher tweet media
English
2
0
33
3.4K
Institute for Musculoskeletal Health
Congratulations to our very own Dr Christina Abdel Shaheed for securing >$2.3M in funding for the IMPLORE trial - an opioid stewardship intervention to reduce opioid use. An even more impressive achievement given the overall 6.9% success rate👉 bit.ly/3zEgow9
English
5
3
28
0
Dr Irwin Lim
Dr Irwin Lim@_connectedcare·
Ouch! Terrible adherence rates for gouts. Why? Why? For this "curable" disease #2021araasm
Dr Irwin Lim tweet media
English
3
3
6
0
Ric Day
Ric Day@osbornidayius·
DIA: Driving Insights to Action podbean.com/pu/pbblog-n5z2… John Skeritt, Head of TGA & I chat about "Australia: Growing Clinical Trials Even in Pandemic’s Wake"
English
0
0
1
0
Ric Day
Ric Day@osbornidayius·
@Pain_NeuRa Well done James and hearty congratulations!
English
1
0
0
0
James McAuley
James McAuley@Pain_NeuRa·
New year - new academic position for me. As of today, I am a Professor 🧐
English
61
3
400
0